6-K filed Nov 9, 2026 at 14:41 ET
Fresenius Medical Care placed a €500 million bond maturing in February 2032 with a 4.250% coupon, issued at 99.497% (yield 4.363%). Proceeds will be used for general corporate purposes, including refinancing existing debt. This is a routine debt capital markets transaction with no material impact on equity value.